✦ LIBER ✦

S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas

✍ Scribed by Smith, S L; Gugger, M; Hoban, P; Ratschiller, D; Watson, S G; Field, J K; Betticher, D C; Heighway, J

Book ID: 109998291
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 403 KB
Volume: 91
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S100A2–S100P expression profile and diag

S100A2–S100P expression profile and diagnosis of non-small cell lung carcinoma: Impairment by advanced tumour stages and neoadjuvant chemotherapy

✍ Babett Bartling; Grit Rehbein; Wolfgang Daniel Schmitt; Hans-Stefan Hofmann; Rol 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 822 KB

The expression of COX-2, hTERT, MDM2, LA

The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC)

✍ Mojca Stražišar; Vid Mlakar; Damjan Glavač 📂 Article 📅 2009 🏛 SP Versita 🌐 English ⚖ 890 KB

## Abstract Several studies have reported different expression levels of certain genes in NSCLC, mostly related to the stage and advancement of the tumours. We investigated 65 stage I-III NSCLC tumours: 32 adenocarcinomas (ADC), 26 squamous cell carcinomas (SCC) and 7 large cell carcinomas (LCC). U

Higher expression of EphA2 and ephrin-A1

Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma

✍ Ishikawa, Masashi; Miyahara, Ryo; Sonobe, Makoto; Horiuchi, Marika; Mennju, Tosh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 656 KB